日本神経精神医学会

2022年8月 - 現在

Glia-driven neuroinflammation and systemic inflammation in Alzheimer’s disease 招待 査読

Hashioka S, Wu Z, Klegeris A

Current Neuropharmacology   2022年7月

Effect of Ninjin’yoeito on lipopolysaccharide-induced depressive-like behavior and glial activation in the hippocampus 査読

Jaya MA, Hayashida M, Tsuchie K, Jerin SJ, Mamunur R, Miura S, Nagahama M, Otsuki K, Hashioka S, Wake R, Miyaoka T, Tanra AJ, Horiguchi J, Inagaki M

Shimane Journal of Medical Science   2022年6月

Improvement in both severe obsessive compulsive disorder and refractory tardive dystonia following electroconvulsive therapy 査読

Mihara Y, Otsuki K, Hayashi M, Yamashita S, Nagahama M, Hayashida M, Wake R, Hashioka S, Abe S, Inagaki M

PCN Reports   2022年5月

Contribution of "genuine microglia" to Alzheimer's disease pathology 招待 査読

Hashioka S, Inoue K, Otsuki K, Hayashida M, Wake R, Kawano N, Takeshita H, Inagaki M

Frontiers in Aging Neuroscience   2022年4月

The use of video games, smartphones, and PCs/tablet PCs based on a survey of students' lifestyles: necessary actions 査読

Inoue K, Fujita Y, Takeshita H, Hashioka S, Kamura M

Public Health   2022年3月

Diversity and regulation of astrocyte neurotoxicity in Alzheimer's disease 招待 査読

Hashioka S, McLarnon JG, Klegeris A

Current Alzheimer Research   2021年12月

Magnetic resonance spectroscopy in the ventral tegmental area distinguishes responders to suvorexant prior to treatment: A 4-week prospective cohort study 査読

Izuhara M, Miura S, Otsuki K, Nagahama M, Hayashida M, Hashioka S, Asou H, Kitagaki H, Inagaki M

Frontiers in Psychiatry   2021年8月

Seeking to address issues with COVID-19 vaccines in Japan and to resolve global problems with vaccination programmes 査読

Inoue K, Ohira Y, Kawano N, Takeshita H, Hashioka S

International Maritime Health   2021年5月

Prompt improvement of difficulty with sleep initiation and waking up in the morning and daytime somnolence by combination therapy of suvorexant and ramelteon in delayed sleep-wake phase disorder 査読

Izuhara M, Kawano K, Otsuki K, Hashioka S, Inagaki M

Sleep Medicine   2021年4月

Studies support the use of suvorexant for the prevention of delirium 査読

Izuhara M, Izuhara HK, Tsuchie K, Araki T, Ito T, Sato K, Miura S, Otsuki K, Nagahama M, Hayashida M, Hashioka S, Wake R, Kimura T, Tsumoto S, Saito Y, Inagaki M

Journal of Clinical Psychiatry   2021年4月

Urinary biopyrrins and free immunoglobin light chains are biomarker candidates for screening at-risk mental state in adolescents 査読

Wake R, Araki T, Fukushima M, Matsuda H, Inagaki T, Hayashida M, Hashioka S, Horiguchi J, Inagaki M, Miyaoka T, Oh-Nishi A

Early Intervention in Psychiatry   2021年3月

Psychosis in a primary hyperparathyroidism patient with mild hypercalcemia 査読

Otsuki K, Izuhara M, Miura S, Yamashita S, Nagahama M, Hayashida M, Hashioka S, Miyaoka T, Hotta Y, Shimizu Y, Inagaki M

Medicine (Baltimore)   2021年3月

Normalizing hyperactivity of the Gunn rat with bilirubin-induced neurological disorders via ketanserin 査読

Miura S, Tsuchie K, Fukushima M, Arauchi R, Tsumori T, Otsuki K, Hayashida M, Hashioka S, Wake R, Miyaoka T, Inagaki M, Oh-Nishi A

Pediatric Research   2021年2月

Do Alzheimer’s disease risk gene products actually act in microglia? 査読

Hashioka S, Inoue K, Takeshita H, Inagaki M

Frontiers in Aging Neuroscience   2020年12月

Drug offenses in the Tokyo metropolitan area: Trends for 2016-2018.

15. Inoue K, Hashioka S, Takeshita H, Fujita Y, Moriwaki S, Murayama Y, Fujita Y, Matsumoto H, Takeichi N, Hoshi M, Noso Y, Okazaki Y

Legal Medicine   2020年11月

Real-world preventive effects of suvorexant in intensive care delirium: A retrospective cohort study 査読

Izuhara M, Izuhara H, Tsuchie K, Araki T, Ito T, Sato K, Miura S, Otsuki K, Nagahama M, Hayashida M, Hashioka S, Wake R, Kimura T, Tsumoto S, Saito Y, Inagaki M

Journal of Clinical Psychiatry   2020年10月

Glia and glial growth factors as new therapeutic targets in neuropsychiatric disorders 招待 査読

Hashioka S

CNS & Neurological Disorders - Drug Targets   2020年7月

Tailgating (aori-unten): A recent major social issue in Japan 査読

Inoue K, Hashioka S, Takeshita H

Medicine, Science and the Law   2020年7月

Low serum levels of fibroblast growth factor 2 in Gunn rats: A hyperbilirubinemia animal model of schizophrenic symptoms 査読

Hayashida M, Hashioka S, Hayashida K, Miura S, Tsuchie K, Araki T, Izuhara M, Kanayama M, Otsuki K, Nagahama M, Jaya AM, WakeR, Oh-Nishi A, Horiguchi J, Miyaoka T, Inagaki M.

CNS & Neurological Disorders - Drug Targets   2020年7月

Risk of an increase in suicide rates associated with economic downturn due to COVID-19 pandemic 査読

Inoue K, Hashioka S, Kawano N

Asia-Pacific Journal of Public Health   2020年7月

Self-assessed competence in providing care to the severely ill patients among nurses and relatives/caregivers in Kazakhstan 査読

Sharapiyeva A, Abzalova R, Inoue K, Hashioka S, Zhetmekova Z

Georgian Medical News   2020年3月

Changes in the status of COVID-19 over time necessitate major changes in academics 査読

Inoue K, Hashioka S, Inagaki T, Takeshita H, Fujita Y, Ohira Y

International Maritime Health   2020年3月

活性化ヒトグリア細胞による神経毒性の研究

2012年4月 - 2015年3月

基盤研究(C)

活性化グリアによる神経炎症に基づいた精神・神経疾患の病態解明 国際共著

2003年4月 - 現在

共同研究 

島根大学法医学講座主催市民公開講座講師

2018年11月

出雲第一中学校すこやか委員会

2017年9月 - 2022年3月

日本生物学的精神医学会　評議員　編集委員

日本神経精神医学会　評議員

日本認知症学会　代議員

日本神経化学会　評議員